ISC 2015 header

AAIC 2015 Conference Coverage

Neurodegenerative Diseases Investigational Neurotransmitter May Improve Cognition in Alzheimer's

Investigational Neurotransmitter May Improve Cognition in Alzheimer's

Promising cognitive-enhancing agents are being investigated.

Neurodegenerative Diseases Exercise May Curb Symptoms of Alzheimer's, Mild Cognitive Impairment

Exercise May Curb Symptoms of Alzheimer's, Mild Cognitive Impairment

Walking, running or swimming may reduce a range of symptoms of neurodegenerative disorders.

Neurodegenerative Diseases Antibodies Targeting Alzheimer's May Benefit Other Prion Diseases

Antibodies Targeting Alzheimer's May Benefit Other Prion Diseases

Monoclonal antibodies targeting tau and beta amyloid in Alzheimer's disease may also benefit other neurodegenerative diseases.

Neurodegenerative Diseases Most Dementia Patients Prescribed Multiple Psychotropic Drugs

Most Dementia Patients Prescribed Multiple Psychotropic Drugs

Younger, female patients were most associated with psychotropic polypharmacy.

Neurodegenerative Diseases AVP-923 Significantly Reduces Agitation in Alzheimer's Disease

AVP-923 Significantly Reduces Agitation in Alzheimer's Disease

Phase-2 study results suggest AVP-923 has meaningful effects in reducing agitation.

Neurodegenerative Diseases Aducanumab Fails to Show Significant Effect on Alzheimer's Progression

Aducanumab Fails to Show Significant Effect on Alzheimer's Progression

Results from Biogen's PRIME study indicated that higher doses were more effective at destroying beta amyloid.

Neurodegenerative Diseases Amyloid PET Scans May Inform Dementia Treatments

Amyloid PET Scans May Inform Dementia Treatments

Clinical trials are underway to evaluate if access to amyloid PET scans affects treatment decisions in dementia.

Neurocognitive Disorders Diagnostic Tool for Neurocognitive Disorders Will Be Evaluated in Trial

Diagnostic Tool for Neurocognitive Disorders Will Be Evaluated in Trial

Researchers have begun enrolling 800 patients in a trial to test the accuracy of the PredictND tool.

Neurodegenerative Diseases Solanezumab May Have Modest Effect on Alzheimer's Disease

Solanezumab May Have Modest Effect on Alzheimer's Disease

Benefit seen in the early treatment group could not be recovered by those for whom treatment was delayed.

Neurodegenerative Diseases Cognitive Impairment Progresses More Rapidly in Women

Cognitive Impairment Progresses More Rapidly in Women

Differences in brain structure, disease progression and biological characteristics may play a role.

Neurodegenerative Diseases Academic Performance in Childhood Predicts Dementia Risk

Academic Performance in Childhood Predicts Dementia Risk

Early academic performance may better indicate cognitive reserve than formal education and occupational complexity.

Neurodegenerative Diseases Alzheimer's Diagnosis Among Baby Boomers Expected to Soar

Alzheimer's Diagnosis Among Baby Boomers Expected to Soar

By 2050, 50% of baby boomers are expected to be diagnosed with Alzheimer's.

Neurodegenerative Diseases New Compound May Prevent Beta Amyloid, Tau Misfolding

New Compound May Prevent Beta Amyloid, Tau Misfolding

Results suggested that TRV 101 prevents oligomerization activity against both beta amyloid and tau.

Neurodegenerative Diseases Saliva May Help Distinguish Between Forms of Cognitive Impairment

Saliva May Help Distinguish Between Forms of Cognitive Impairment

High levels of both metabolites were linked to worse working memory in normally aging people.

Neurodegenerative Diseases Potential Biomarkers May Predict Cognitive Impairment in Alzheimer's

Potential Biomarkers May Predict Cognitive Impairment in Alzheimer's

The biomarkers may be useful for the design of clinical trials.

Upcoming Meetings

Sign Up for Free e-newsletters